- Home
- TRMK vs KYMR Comparison
TRMK vs KYMR Comparison
Compare TRMK & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- KYMR
- Stock Information
- Founded
- TRMK 1889
- KYMR 2015
- Country
- TRMK United States
- KYMR United States
- Employees
- TRMK N/A
- KYMR N/A
- Industry
- TRMK Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- TRMK Finance
- KYMR Health Care
- Exchange
- TRMK Nasdaq
- KYMR Nasdaq
- Market Cap
- TRMK 2.2B
- KYMR 1.8B
- IPO Year
- TRMK 1987
- KYMR 2020
- Fundamental
- Price
- TRMK $34.08
- KYMR $45.87
- Analyst Decision
- TRMK Buy
- KYMR Strong Buy
- Analyst Count
- TRMK 4
- KYMR 16
- Target Price
- TRMK $40.50
- KYMR $59.38
- AVG Volume (30 Days)
- TRMK 244.8K
- KYMR 1.1M
- Earning Date
- TRMK 07-22-2025
- KYMR 08-06-2025
- Dividend Yield
- TRMK 2.82%
- KYMR N/A
- EPS Growth
- TRMK 50.91
- KYMR N/A
- EPS
- TRMK 3.85
- KYMR N/A
- Revenue
- TRMK $544,423,000.00
- KYMR $58,885,000.00
- Revenue This Year
- TRMK $57.13
- KYMR $43.38
- Revenue Next Year
- TRMK $3.95
- KYMR $10.97
- P/E Ratio
- TRMK $8.85
- KYMR N/A
- Revenue Growth
- TRMK N/A
- KYMR N/A
- 52 Week Low
- TRMK $28.32
- KYMR $19.45
- 52 Week High
- TRMK $40.73
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- TRMK 45.36
- KYMR 67.58
- Support Level
- TRMK $33.39
- KYMR $45.80
- Resistance Level
- TRMK $34.84
- KYMR $47.51
- Average True Range (ATR)
- TRMK 0.68
- KYMR 2.86
- MACD
- TRMK -0.12
- KYMR -0.03
- Stochastic Oscillator
- TRMK 30.94
- KYMR 67.19
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.